Congratulations RA team!
We are happy to inform that we have received the approval of our Dimethyl Fumarate 120 and 240 mg GR capsules DCP (DE/H/7868/001-002/DC) in Germany and France. These MAs shall be available for transfer to our partners. Dimethyl Fumarate is used for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (RRMS).
Feel free to contact our team for further information.
